scholarly journals How are the women in Germany? The Women’s Health Report of German Federal Health Reporting

2020 ◽  
Vol 30 (Supplement_5) ◽  
Author(s):  
F Prütz ◽  
B Hintzpeter ◽  
L Krause ◽  
A-C Saß

Abstract Issue The aim of Federal health reporting (GBE) is to continuously provide up-to-date information on the population's health and healthcare utilisation in Germany. Since women and men differ significantly in terms of health and disease, health reporting should always take gender into account. Description of the Problem A new report on women's health in Germany is published in mid-2020 by the Robert Koch Institute (RKI), containing data on women's health situation, health behaviour and health care. GBE publications are based on a comprehensive database, including official statistics, RKI health monitoring data, routine data and cancer registry data. We will present exemplary data on key indicators of the report. Results Life expectancy of women in Germany has been rising for many decades. With currently 83.2 years, it is at the EU average. Cardiovascular diseases are still the leading cause of death, accounting for 40% of all deaths. The second leading cause of death in women is cancer. With about 69,000 new cases per year, breast cancer is most common, although incidence and mortality rates have significantly declined. 53% of women in Germany are overweight (EU: 44%), 22% undertake health-enhancing physical activities at least once a week (EU: 10%), the 30-day prevalence of binge drinking is 19% (EU: 10%). Women with a migration background have a lower prevalence of risky alcohol consumption and practice physical activities less frequently. A low birth rate and the postponement of the first birth to a later age are characteristic for Germany (summarized birth rate: 1.57). The caesarean section rate slightly decreased to 30.5% in 2017. In 2018 there were 100,986 terminations of pregnancy, with a declining trend. Lessons The Women's Health Report provides an overview of key issues of women's health in Germany. These can help to improve prevention and health care. In some areas (e.g. benign gynaecological diseases), there are still data gaps in spite of high prevalences. Key messages The Women's Health Report of Federal Health Reporting is published in mid-2020 and provides an overview of key issues of women's health in Germany. Women’s life expectancy in Germany has been rising for many decades and is currently 83.2 years, with cardiovascular diseases and cancer still being the most common causes of death.

2018 ◽  
Vol 11 ◽  
pp. 1179562X1875746 ◽  
Author(s):  
Rebecca Ashkenazy ◽  
Mary Elizabeth Peterson

There are powerful demographic, political, and environmental trends shaping women’s health. Increases in life expectancy, literacy, and empowerment are fueling expansions in education and advocacy. Research and development focuses on women’s health and fertility across an expanded age spectrum. There is also a cultural emphasis on antiaging and aesthetics. In parallel, the digital revolution is changing how health care is accessed by and delivered to women. A women’s journey through menopause is at the crossroads of these transformations. Medical and social platforms encourage women to embrace menopause as a pivotal life stage. Yet, many women are reticent to discuss “the transition” due to embarrassment about its symptoms, lack of awareness of its physical manifestations, or fear of aging. We introduce a patient-centric framework to support patient-provider engagement on menopause: prevention, anxiety, urogenital symptoms, vasomotor symptoms, and education. Although not comprehensive, PAUSE represents an acronym and reminder to focus a portion of the medical interaction on menopause.


2004 ◽  
Author(s):  
Caitlin S. Shannon ◽  
Beverly Winikoff

On May 7–8, 2001, the Population Council and the Center for Reproductive Health Research & Policy of the University of California, San Francisco, convened a technical seminar in New York City on the use of misoprostol for women’s health indications. The seminar was designed to provide a forum for researchers, providers, women’s health advocates, and educators to exchange information with the goal of advancing the potential of misoprostol to improve women’s health. Participants discussed the state of the art in research, examined current clinical use of misoprostol, and created strategies for the future. The first day focused on scientific and clinical aspects of misoprostol use. The second day’s discussion centered on the future of misoprostol for women’s health, including identifying priorities for research and the role of provider groups and women’s health and advocacy organizations in helping to ensure misoprostol’s continued, appropriate use. At the end of each session, the group had an opportunity to share ideas and discuss unanswered questions. This report covers the key issues raised by each speaker and highlights general areas of discussion among participants.


Author(s):  
Jummi Park ◽  
Nayeon Shin

Online-based infertility education provides a health management system to patients using electronic information and technology and no face-to-face interaction with patients and experts. This is a study to develop a web-based integrated support service system to meet the health care and nursing needs of infertile women. To develop a system that is most suitable and practically helpful to infertile women, who are end users of this system, research was conducted. This education system consists of introduction to women’s health care, information on women’s health, information on organizations for women, community for infertile women, and request for consultation for health management and nursing education of infertile women. This study introduced and applied a user-centered design that maximizes the value of use by first understanding the user’s convenience and needs when developing a program.


Sign in / Sign up

Export Citation Format

Share Document